ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Zhongzhi Pharmaceutical Holdings Ltd. ?
1
High Management Efficiency with a high ROE of 12.09%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 24.50
3
Poor long term growth as Operating profit has grown by an annual rate -11.90% of over the last 5 years
4
Negative results in Dec 24
- ROCE(HY) Lowest at 8.81%
- NET PROFIT(Q) Lowest at HKD 12.77 MM
- EPS(Q) Lowest at HKD 0.02
5
With ROE of 1.88%, it has a Very Attractive valuation with a 0.57 Price to Book Value
- Over the past year, while the stock has generated a return of -21.51%, its profits have fallen by -81.6%
- At the current price, the company has a high dividend yield of 642.3
6
Underperformed the market in the last 1 year
- Even though the market (Hang Seng Hong Kong) has generated returns of 18.06% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -21.51% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhongzhi Pharmaceutical Holdings Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhongzhi Pharmaceutical Holdings Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zhongzhi Pharmaceutical Holdings Ltd.
-21.51%
-0.55
54.56%
Hang Seng Hong Kong
18.06%
0.71
25.51%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.26%
EBIT Growth (5y)
-11.90%
EBIT to Interest (avg)
24.50
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
1.63
Tax Ratio
34.56%
Dividend Payout Ratio
40.95%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.58%
ROE (avg)
12.09%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
0.57
EV to EBIT
7.63
EV to EBITDA
3.72
EV to Capital Employed
0.59
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
642.31%
ROCE (Latest)
7.68%
ROE (Latest)
1.88%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Zhongzhi Pharmaceutical Holdings Ltd.
Dividend Payout Ratio
Highest at 331.13%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Here's what is not working for Zhongzhi Pharmaceutical Holdings Ltd.
Net Profit
Lowest at HKD 12.77 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
Net Profit
Fallen at -57.79%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD 0.02
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
